Alzheimer's 'First' Achieved With Drug That Hits Hotspots
Scientists say they have achieved a "first" in the development of drugs to treat Alzheimer's disease. In a study published in the journal Alzheimer's & Dementia, a team of researchers report the ...
psychiatryadvisor.com2d
Delirium vs Dementia in Older Adults: Types, Symptoms, and Diagnosis
Our easy-to-read patient fact sheet provides clinicians with information on the symptoms of delirium vs dementia and AD.
A Promising 'First' in Alzheimer's Drug Development
An international team of researchers led by Lancaster University have made a promising breakthrough in the development of drugs to treat Alzheimer’s Disease. For the first time, scientists have ...
BioWorld2d
RI-AG03 targets main promoters of tau protein aggregation at once
The increasing knowledge on how protein tau is organized in live cells has shown that the protein forms nanometer-sized ...
Breakthrough Alzheimer’s Drug Prevents Toxic Protein Build-up In Brain
Researchers from a study funded by the Alzheimer’s Society of UK have developed a new drug known as RI-AG03 that they say can ...
Neuroscience News2d
Dual-Targeting Drug Halts Tau Accumulation in Alzheimer’s
Scientists have developed a drug that targets both major aggregation-promoting sites of the Tau protein, a key player in ...
Science Daily3d
Promising 'first' in Alzheimer's drug development
An international team of researchers have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease. For the first time, scientists have developed a drug that works on ...
mashviral3d
New Alzheimer’s Drug, RI-AG03, Shows Promise in Preliminary Trials
A team of researchers has reported a significant advance in Alzheimer’s treatment. Their candidate drug, RI-AG03, attacks the ...
News Medical3d
Researchers make breakthrough in Alzheimer's disease drug development
An international team of researchers led by Lancaster University have made a promising breakthrough in the development of drugs to treat Alzheimer's Disease.
IGC Pharma Wins 2 Prizes in Phase 1 of National Institutes of Health's AI PREPARE Challenge
POTOMAC, MD / ACCESSWIRE / October 3, 2024 / IGC Pharma, Inc. (NYSE American:IGC) proudly announces that it won 2 awards in ...
Alzheimer’s breakthrough after drug treatment success
Researchers have hailed a breakthrough in the development of drugs to treat Alzheimer’s.Scientists have created a drug that ...
Key mechanisms in asymptomatic Alzheimer's disease brains offer potential protection against cognitive decline
Researchers at Indiana University School of Medicine are examining the brains of individuals with asymptomatic Alzheimer's ...